As of 2025-05-21, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (21.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.60 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -381.4%.
The range of the Relative Valuation is (18.68) - (20.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.2x | 17.0x |
| Forward P/E multiples | 15.4x - 19.1x | 18.4x |
| Fair Price | (18.68) - (20.76) | (21.38) |
| Upside | -345.8% - -373.2% | -381.4% |
| Date | P/E |
| 2025-05-14 | -5.73 |
| 2025-05-13 | -5.79 |
| 2025-05-12 | -6.11 |
| 2025-05-09 | -5.84 |
| 2025-05-08 | -6.16 |
| 2025-05-07 | -5.83 |
| 2025-05-06 | -5.93 |
| 2025-05-05 | -6.39 |
| 2025-05-02 | -7.27 |
| 2025-05-01 | -7.05 |
| 2025-04-30 | -6.86 |
| 2025-04-29 | -6.79 |
| 2025-04-28 | -6.72 |
| 2025-04-25 | -6.37 |
| 2025-04-24 | -6.53 |
| 2025-04-23 | -6.49 |
| 2025-04-22 | -6.54 |
| 2025-04-21 | -6.29 |
| 2025-04-17 | -6.04 |
| 2025-04-16 | -5.93 |
| 2025-04-15 | -6.22 |
| 2025-04-14 | -6.26 |
| 2025-04-11 | -5.88 |
| 2025-04-10 | -5.29 |
| 2025-04-09 | -5.65 |
| 2025-04-08 | -4.98 |
| 2025-04-07 | -5.21 |
| 2025-04-04 | -5.25 |
| 2025-04-03 | -5.79 |
| 2025-04-02 | -6.07 |
| 2025-04-01 | -5.41 |
| 2025-03-31 | -6.06 |
| 2025-03-28 | -6.27 |
| 2025-03-27 | -6.41 |
| 2025-03-26 | -6.34 |
| 2025-03-25 | -6.22 |
| 2025-03-24 | -6.30 |
| 2025-03-21 | -6.21 |
| 2025-03-20 | -6.15 |
| 2025-03-19 | -6.36 |
| 2025-03-18 | -6.16 |
| 2025-03-17 | -6.56 |
| 2025-03-14 | -6.38 |
| 2025-03-13 | -6.51 |
| 2025-03-12 | -6.97 |
| 2025-03-11 | -7.03 |
| 2025-03-10 | -6.32 |
| 2025-03-07 | -6.23 |
| 2025-03-06 | -6.07 |
| 2025-03-05 | -5.91 |